ロード中...
Suitability of Xpert MTB/RIF and Genotype MTBDRplus for Patient Selection for a Tuberculosis Clinical Trial
Participation criteria for clinical trials in pulmonary tuberculosis commonly include confirmation of sputum positive for mycobacteria and an indication of drug susceptibility before treatment is initiated. We investigated the suitability of two novel sputum-based nucleic acid amplification methods...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3147741/ https://ncbi.nlm.nih.gov/pubmed/21653771 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.00138-11 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|